SEC Form 4 · accession 0001179022-17-000029
GALECTIN THERAPEUTICS INC · GALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Theodore Daniel Zucconi
Director
Period of report
May 23, 2017
Accepted (ET)
May 24, 2017 · 9:39 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001133416
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | May 23, 2017 | P | 1,000 | $2.27 | A | 1,083 | D |
Table II — derivative securities
No Table II lines on this filing.